Biogen MA Inc. et al v. Cipla Ltd. et al
| Biogen MA Inc. and Biogen Inc. |
| Cipla Ltd. and Cipla USA, Inc. |
| 1:2026cv00736 |
| June 22, 2026 |
| U.S. District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 23, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 6 Summons Issued as to Cipla Ltd. on 6/23/2026; Cipla USA, Inc. on 6/23/2026. (Attachments: #1 Summons Issued)(oam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc. for Biogen MA Inc. filed by Biogen Inc., Biogen MA Inc.. (oam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,926,559 B2; 10,436,802 B2; 12,013,403 B2. (oam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/19/2026. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/19/2028. (oam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
| Filing 1 COMPLAINT against Cipla Ltd., Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4997624) - filed by Biogen Inc., Biogen MA Inc.. (Attachments: #1 Exhibits A-C, #2 Civil Cover Sheet)(oam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
